$53.01
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+0.13%
1Y
+11.13%
YTD
+12.38%
Open$53.01
Previous Close$53.01
Day High$53.01
Day Low$53.01
52W High$69.99
52W Low$29.43
Volume—
Avg Volume1.80M
Market Cap2.76B
P/E Ratio28.77
EPS$1.70
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.79
Above
SMA 200
$52.40
Above
RSI (14)
93.1
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Hold
16 analysts
Price Target
-62.4% upside
Current
$53.01
$53.01
Target
$19.95
$19.95
$16.99
$19.95 avg
$27.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 189.44M | 785.64M | 787.82M |
| Net Income | 20.79M | 73.80M | 76.85M |
| Profit Margin | 11.0% | 9.4% | 9.8% |
| EBITDA | 11.37M | 123.66M | 121.59M |
| Free Cash Flow | — | 65.88M | 73.67M |
| Rev Growth | +298.9% | +24.2% | +9.0% |
| Debt/Equity | 0.11 | 0.21 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |